CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity
about
NK Cell Subtypes as Regulators of Autoimmune Liver DiseaseHuman Circulating and Tissue-Resident CD56(bright) Natural Killer Cell PopulationsRecognition and Regulation of T Cells by NK CellsThe Immunogenicity of Colorectal Cancer in Relation to Tumor Development and TreatmentUnderground Adaptation to a Hostile Environment: Acute Myeloid Leukemia vs. Natural Killer CellsCord Blood as a Source of Natural Killer CellsEffector Functions of Natural Killer Cell Subsets in the Control of Hematological MalignanciesNatural killer cell biology: an update and future directionsNK cell therapy: targeting disease relapse after hematopoietic stem cell transplantationSubsets of human natural killer cells and their regulatory effectsThe role of natural cytotoxicity receptors in various pathologies: emphasis on type I diabetesPositive and negative regulation by NK cells in cancerIn vivo monitoring of natural killer cell trafficking during tumor immunotherapyDaclizumab therapy for multiple sclerosisHuman NK Cell Subsets Redistribution in Pathological Conditions: A Role for CCR7 ReceptorFunctional Reconstitution of Natural Killer Cells in Allogeneic Hematopoietic Stem Cell TransplantationDysregulation of Chemokine/Chemokine Receptor Axes and NK Cell Tissue Localization during DiseasesHuman congenital infection with Trypanosoma cruzi induces phenotypic and functional modifications of cord blood NK cellsInterleukins 2 and 15 regulate Ets1 expression via ERK1/2 and MNK1 in human natural killer cellsSynergistic effect between amoxicillin and TLR ligands on dendritic cells from amoxicillin-delayed allergic patientsProteome analysis of distinct developmental stages of human natural killer (NK) cellsPartially randomized, non-blinded trial of DNA and MVA therapeutic vaccines based on hepatitis B virus surface protein for chronic HBV infection.The natural killer cell response to West Nile virus in young and old individuals with or without a prior history of infectionDistinct Migration and Contact Dynamics of Resting and IL-2-Activated Human Natural Killer Cells.Rapid activation receptor- or IL-2-induced lytic granule convergence in human natural killer cells requires Src, but not downstream signalingGenome wide transcriptional analysis of resting and IL2 activated human natural killer cells: gene expression signatures indicative of novel molecular signaling pathways.Integration of clinical data, pathology, and cDNA microarrays in influenza virus-infected pigtailed macaques (Macaca nemestrina)Tonsilar NK cells restrict B cell transformation by the Epstein-Barr virus via IFN-gamma.Impaired NK-cell migration in WAS/XLT patients: role of Cdc42/WASp pathway in the control of chemokine-induced beta2 integrin high-affinity stateBoth conventional and interferon killer dendritic cells have antigen-presenting capacity during influenza virus infection.Human natural killer cell development in secondary lymphoid tissuesCD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets.Licensing delineates helper and effector NK cell subsets during viral infection.NK cells in HIV-1 infection: evidence for their role in the control of HIV-1 infection.Beyond NK cells: the expanding universe of innate lymphoid cells.HIV-1-specific T Cell-dependent natural killer (NK) cell activation: major contribution by NK cells to interferon-gamma production in response to HIV-1 antigens.Human CD56dimCD16dim Cells As an Individualized Natural Killer Cell Subset.Compartmentalization of innate immune responses in the central nervous system during cryptococcal meningitis/HIV coinfectionCD16- natural killer cells: enrichment in mucosal and secondary lymphoid tissues and altered function during chronic SIV infectionDNA-based vaccines activate innate and adaptive antitumor immunity by engaging the NKG2D receptor.
P2860
Q26741392-B08F5D4E-D3D4-47CC-A25D-BA29DDB71BE7Q26742158-7918629A-88BE-463A-B729-B5D75328962BQ26742166-0AF00B6C-3B3B-4E3A-BDB5-53CF40603CE7Q26745580-28F9F62A-4D28-4587-9FDC-F86D242D6E57Q26751011-0D648F8A-221E-491E-A889-706F0E026F3DQ26771337-80B81618-05C3-43BE-A5AF-A5ED2208454CQ26776538-EAC92B63-9763-44DD-9AF3-124521D6AEA6Q26830512-FD58BFD1-F1AE-4673-8E28-A74196BCB6F2Q26863559-FED9F251-D68D-42DB-B08C-BABF5D4E07E2Q26996034-C0F121BF-1C72-4086-A165-1B079BDA0F35Q27003384-18784B84-27D4-4668-8924-A2D2F88D4CFDQ27004658-16213EF4-4D79-4593-9608-84689DAAE950Q27011245-0FC99DBE-9470-41F5-969B-636D9431819BQ27022517-228E1D8D-5E45-4661-A82F-E0A4E945DE4EQ28067468-9F04D924-272B-4AA4-860A-DAB6FBB9F2E0Q28069682-573F0553-C0E3-4C8C-A0D0-8683ECE6916DQ28079140-30332E1A-4650-40BA-AF6F-3B31BCB090B5Q28239745-E220285F-F601-4B83-A802-6F6F7E8E2E7EQ28295106-C5122621-5B3B-40ED-99FC-7F91B74403CBQ28533519-0D656244-BF7C-4A01-8B76-723BBC6B0858Q28704450-BF361593-0DC7-4C85-B871-D983D55A9E94Q28742762-82CF2E84-35C5-423F-915A-AFAD493EE0CBQ29365826-248A7179-BE38-433C-9624-D7549DE88F1BQ30441681-860EC1F9-66E3-4E3D-BC3A-E46592B6F4D2Q30538416-EEEA54E5-8231-4CA1-9956-C41511F6B9A6Q30832554-4C439EC2-D196-449B-8469-345B4EAD383FQ33206816-83B30BC7-9DE1-4EFF-942E-21123FB9193EQ33319277-F96E1D76-C097-4C45-8832-B263A72ECC8BQ33388105-6525DFCB-EDC0-4943-A026-08A6FE4F6DC9Q33507092-08AFC5C6-E1C1-4A48-9AC5-35FD442907B1Q33567199-E546A647-0787-4FC8-89BF-CD03A1F939C4Q33597507-9AF3349C-2ED0-4A99-A696-1B260E4DC8A1Q33703214-75438371-5CF5-49D5-8464-E4CB185299B1Q33741498-FA49F655-70BA-48E3-86B6-923B96621302Q33759935-F16AFEFE-7C93-4476-B7AB-E230527F8002Q33786292-9EE3BBB8-2FDD-4A54-A5C2-362ABC877B00Q33810001-B912882D-B3C7-4F8F-B4D0-8F51275EDE5AQ33831703-E273E3FF-E635-4FB6-AB1F-5A21BB5278A1Q33896743-476898C4-25E3-4D98-A267-EE919263827AQ33911460-1FB4AF05-06EC-4FC1-87BA-850D9FC0DC23
P2860
CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity
description
im April 2003 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 12 December 2002
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2003
@uk
name
CD56bright natural killer cell ...... n adaptive and innate immunity
@en
CD56bright natural killer cell ...... n adaptive and innate immunity
@nl
type
label
CD56bright natural killer cell ...... n adaptive and innate immunity
@en
CD56bright natural killer cell ...... n adaptive and innate immunity
@nl
prefLabel
CD56bright natural killer cell ...... n adaptive and innate immunity
@en
CD56bright natural killer cell ...... n adaptive and innate immunity
@nl
P2093
P50
P1433
P1476
CD56bright natural killer cell ...... n adaptive and innate immunity
@en
P2093
Gerard J Nuovo
Megan A Cooper
Michael A Caligiuri
P304
P356
10.1182/BLOOD-2002-09-2876
P407
P577
2002-12-12T00:00:00Z